STERIS plc (Ireland) - Consensus Indicates Potential 13.9% Upside - DirectorsTalk Interviews

2022-08-14 04:30:32 By : Ms. Rita Guo

STERIS plc (Ireland) found using ticker (STE) have now 6 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 250 and 225 with the average target price sitting at 239.5. With the stocks previous close at 210.21 this now indicates there is a potential upside of 13.9%. The 50 day MA is 211.97 and the 200 moving average now moves to 226.87. The market capitalisation for the company is $21,407m. Company Website: https://www.steris.com

The potential market cap would be $24,390m based on the market concensus.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Good news travels fast (but only if you make that happen). Share on:

View all Sustainable sectors, Plcs and news »  

View all Question and Answers

View all Funds, Market Insights and news »

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.